Equibles does not estimate personal net worth.
Get an email with a short summary when Lb Pharmaceuticals Inc publishes a filing, an earnings call transcript or a press release.
Get LBRX alertsGad Soffer is recorded as COO at Lb Pharmaceuticals Inc (LBRX) since March 4, 2026. Gad Soffer has spoken on 1 investor event across 1 company, most recently for Lb Pharmaceuticals Inc on June 4, 2026. Lb Pharmaceuticals Inc is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Lb Pharmaceuticals Inc includes Heather Turner (CEO and Board Member), Joseph M. Miller (CFO) and Robert A. Lenz (Board Member).
“Very excited to take you through the LB Pharma story. As you'll hear, our lead asset, LB 102, is biologically and clinically de-risked. and moving forward in late stage development across schizophrenia, bipolar depression, and MDD.”
2026-03-04–present
Proxy statement
Start not stated–present
Last confirmed April 23, 2026
Biotechnology · Healthcare
COO
2026-03-04–present
